Suchergebnisse - "Sundahl, Nora"

PubPharm (8)

1

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial

enthalten in: BMC cancer | 2021

von Spaas, M. | Sundahl, N. | Hulstaert, E. | +14

2

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS): study protocol for a phase 2, open-label, randomized controlled trial

enthalten in: BMC cancer | 2021

von Spaas, M. | Sundahl, N. | Hulstaert, E. | +14

3

Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial Carcinoma

enthalten in: European urology | 2019

von Sundahl, N. | Vandekerkhove, G. | Decaestecker, K. | +14

4

Combined high dose radiation and pazopanib in metastatic renal cell carcinoma : a phase I dose escalation trial

enthalten in: Radiation oncology (London, England) | 2017

von De Wolf, K. | Rottey, S. | Vermaelen, K. | +9

5

Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial

enthalten in: Radiation oncology | 2017

von De Wolf, K. | Rottey, S. | Vermaelen, K. | +9

6

A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma : evaluation of clinical and immunologic response

enthalten in: Journal of translational medicine | 2017

von De Wolf, K. | Kruse, V. | Sundahl, N. | +5

7

A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic response

enthalten in: Journal of translational medicine | 2017

von De Wolf, K. | Kruse, V. | Sundahl, N. | +5

8

A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic response

enthalten in: Journal of translational medicine | 2017

von De Wolf, K. | Kruse, V. | Sundahl, N. | +5

1
[1]